Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cincinnati Wellness Review.
Press releases published on April 4, 2025
PacBio Grants Equity Incentive Award to New Employee
GlobeNewswire
·
April 4, 2025
MENLO PARK, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted a non- …
AIM ImmunoTech Announces NYSE American Notice of Delisting and Appeal
GlobeNewswire
·
April 4, 2025
OCALA, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (“AIM” or the “Company”) (NYSE American: AIM), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and …
Alumis and ACELYRIN File Joint Definitive Proxy Statement for Proposed Merger
GlobeNewswire
·
April 4, 2025
Stockholders to benefit from differentiated late-stage portfolio of therapies and strong balance sheet Boards unanimously recommend stockholders vote “FOR” the merger Transaction expected to be completed in second quarter of 2025 SOUTH SAN FRANCISCO, Calif …
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
WALTHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …
Breaking Barriers in Autism: European Wellness Biomedical Group Unveils Bioregenerative Breakthroughs with Prof. Mike Chan
GlobeNewswire
·
April 4, 2025
BAODING, China, April 05, 2025 (GLOBE NEWSWIRE) -- European Wellness Biomedical Group (EWBG), a global pioneer in bioregenerative medicine and wellness innovation, today unveiled new breakthroughs in autism-focused therapies under the leadership of Prof. …
Edesa Biotech Announces Chief Financial Officer Transition
GlobeNewswire
·
April 4, 2025
TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced the appointment of Peter J. Weiler …
Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
CAMBRIDGE, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high …
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that on April 1, 2025 the Company granted inducement …
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
REDWOOD CITY, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted an inducement award consisting of non-qualified stock options to …
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
NAARDEN, the Netherlands and MIAMI, April 04, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients …
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
WESTLAKE VILLAGE, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an …
American Nurses Enterprise Names New Chief Nursing Officer
GlobeNewswire
·
April 4, 2025
SILVER SPRING, MD, April 04, 2025 (GLOBE NEWSWIRE) -- The American Nurses Enterprise, which includes the American Nurses Association, the American Nurses Credentialing Center, and the American Nurses Foundation, is pleased to announce the appointment of …
Canadian Pet Population Survey Highlights the Importance of Access to Veterinary Care
GlobeNewswire
·
April 4, 2025
TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- The latest findings from the 2024 Canadian Pet Population Survey reveal significant insights into the pet ownership landscape in Canada. Conducted by Léger, a leading Canadian research and analytics firm, the …
Le sondage sur la population des animaux de compagnie au Canada souligne l’importance de l’accès aux soins vétérinaires
GlobeNewswire
·
April 4, 2025
TORONTO, 04 avr. 2025 (GLOBE NEWSWIRE) -- Les derniers résultats du sondage sur la population canadienne des animaux de compagnie 2024 révèlent des informations importantes sur les propriétaires d’animaux de compagnie au Canada. Mené par Léger, une firme …
Bispecific Trispecific Antibodies Market Size FDA Approval Clinical Trials Drug Sales Insight 2030
GlobeNewswire
·
April 4, 2025
Delhi, April 04, 2025 (GLOBE NEWSWIRE) -- Over the last two decades, immunotherapy has transformed treatment strategies across various medical fields. The effectiveness of monoclonal antibodies in specifically targeting certain antigens has led to the …
Better Choice Company Chairman Provides Shareholder Update on SRx Health Acquisition and Comments on Recent Debt-to-Equity Transaction
GlobeNewswire
·
April 4, 2025
TAMPA, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, Chairman, Michael Young, today provides shareholders with a update on its SRx Health …
Medical Filtration Market worth $9.35 billion by 2030, at a 6.8%, says MarketsandMarkets™
GlobeNewswire
·
April 4, 2025
Delray Beach, FL, April 04, 2025 (GLOBE NEWSWIRE) -- In terms of value, the Medical Filtration Market Is projected to reach USD 9.35 billion by 2030 at a CAGR of 6.8%, as per the recent study by MarketsandMarkets™. The combination of regulatory frameworks, …
NurExone Biologic Announces U.S. Uplisting Intention and Closes C$2.3 Million Private Placement
GlobeNewswire
·
April 4, 2025
TORONTO and HAIFA, Israel, April 04, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX, OTCQB: NRXBF, Germany: J90) (“NurExone” or the “Company”) is pleased to announce that, subject to TSX Venture Exchange (“TSXV”) approval, it has closed a non- …
Better Choice Company Signs Definitive Agreement for SRx Health Solutions to Convert CAD$4 Million in Debt to Equity
GlobeNewswire
·
April 4, 2025
TAMPA, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, is pleased to announce that SRx Health Solutions, Inc. (“SRx Health”) has signed a …
Dental Equipment Market worth US$9.3 Billion by 2029 driven by Specialized Dental Equipment | MarketsandMarkets™.
GlobeNewswire
·
April 4, 2025
Delray Beach, FL, April 04, 2025 (GLOBE NEWSWIRE) -- The global dental equipment market , valued at US$6.5 billion in 2023, is forecasted to grow at a robust CAGR of 6.2%, reaching US$6.9 billion in 2024 and an impressive US$9.3 billion by 2029. The dental …